TLRY | Tilray, Inc.

Tilray Q2 Earnings Leave Investors Wanting More
While Tilray has maintained its leading market share in the recreational cannabis market in Canada and the medical cannabis market in Europe, its Q2 earnings, which included a loss per share of -$0.11 and an adjusted loss per share of -$0.06, have left investors questioning the company's future growth prospects.
By Staff | 1 year ago

If you love penny stocks, then hold these for the week
Today we're looking at two penny stocks that will perform well this week.
By Precious Njoku | 1 year ago

2 Stocks to Watch if Cannabis Gains Federal Legalization
The cannabis industry is fragmented following state legalization over the past decade.
By Mike Sakuraba | 2 years ago

Tilray; capturing the cannabis market with another acquisition
With the acquisition of Breckenridge Distillery, Tilray is undergoing a horizontal expansion to increase its offering in the beverage alcohol sector.
By Precious Njoku | 2 years ago

2 Cannabis Stocks off to a Hot Start in February
Let’s take a look at a couple of cannabis stocks that are off to a hot start in February.
By Mike Sakuraba | 3 years ago

The Future of Cannabis Stocks in 2021
When is the right time to buy stock in the cannabis market? The time is now!
By Staff | 3 years ago

Tilray expects to report cannabis sales growth in the fiscal Q2
Here's what analysts' are forecasting for Tilray's Q2 earnings report on Monday.
By Khan | 3 years ago